Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir

Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir

NYTimes.com

Published

Neither the company nor the institutes discussed the data. Previous results for the potential coronavirus treatment have been inconclusive.

Full Article